CareCloud, Inc. — Capital/Financing Update 2018

Oct 11, 2018

S-1MEF 1 forms-1mef.htm

As filed with the Securities and Exchange Commission on October 10, 2018.

Registration No. 333- _____

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Field: Rule-Page

Field: /Rule-Page

FORM S-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

Field: Rule-Page

Field: /Rule-Page

MEDICAL TRANSCRIPTION BILLING, CORP.

(Exact name of registrant as specified in its charter)

Delaware	7389	22-3832302
(State
or other jurisdiction of incorporation
or organization)	(Primary
Standard Industrial Classification
Code Number)	(I.R.S.
Employer Identification
Number)

Field: Rule-Page

Field: /Rule-Page

7 Clyde Road

Somerset, New Jersey 08873

(732) 873-5133

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

Field: Rule-Page

Field: /Rule-Page

Stephen Snyder Chief Executive Officer

7 Clyde Road

Somerset, New Jersey 08873

(732) 873-5133

(Name, address, including zip code, and telephone number, including area code, of agent for service)

Field: Rule-Page

Field: /Rule-Page

Copies of communications to:

David S. Song, Esq. Peter B. Katzman, Esq. Song P.C. 444 Madison Avenue, 4th Floor New York, New York 10022 (212) 599-0700 Gregory Sichenzia, Esq. Thomas Rose, Esq. Jay Yamamoto, Esq. Sichenzia Ross Ference LLP 1185 Avenue of the Americas, 37 th Floor New York, New York 10036 (212) 930-9700

Field: Rule-Page

Field: /Rule-Page

Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement.

Field: Rule-Page

Field: /Rule-Page

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. [X]

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [X] No. 333-227524

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

| Large
accelerated filer [ ] | Accelerated
filer [ ] |
| --- | --- |
| Non-Accelerated
filer [ ] | Smaller
reporting company [X] |
| | Emerging
growth company [X] |

Field: Rule-Page

Field: /Rule-Page

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided to Section 7(a)(2)(B) of the Securities Act. [X]

CALCULATION OF REGISTRATION FEE

| Title
of Each Class
of Securities to
be Registered — Series A Preferred Stock, $0.001 par value
per share | 100,000 | Proposed Maximum Offering Price
per Share — $ 25.00 | Estimated Proposed Maximum Aggregate Offering
Price — $ 2,500,000 | (1) | Amount
of Registration Fee (2) — $ 303.00 | (3) |
| --- | --- | --- | --- | --- | --- | --- |

| (1) | Represents
only the additional number of shares being registered. This does not include the securities that the Registrant previously
registered on the Registration Statement on Form S-1, as amended (File No. 333-227524) (“Prior Registration Statement”). |
| --- | --- |
| (2) | Calculated
pursuant to Rule 457(a) based on an estimate of the proposed maximum aggregate offering price. |
| (3) | A registration fee of $3,112.50 was previously paid. |

This Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) under the Securities Act.

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Explanatory Note and Incorporation of Certain Information by Reference

Pursuant to Rule 462(b) under the Securities Act of 1933, as amended, Medical Transcription Billing, Corp. (“Registrant”) is filing this registration statement with the Securities and Exchange Commission (the “Commission”). This registration statement relates to the public offering of securities contemplated by the Registration Statement on Form S-1, as amended (File No. 333-227524) (“Prior Registration Statement”), which the Commission declared effective on October 10, 2018 .

The Registrant is filing this registration statement for the sole purpose of increasing the aggregate number of shares of 11% Series A Cumulative Redeemable Perpetual Preferred Stock offered by the Registrant by 100,000 shares. The additional securities that are being registered for sale are in an amount and at a price that together represent no more than 20% of the maximum aggregate offering price set forth in the Calculation of Registration Fee table contained in the Prior Registration Statement. The information set forth in the Prior Registration Statement and all exhibits thereto are hereby incorporated by reference in this filing.

The required opinion and consents are listed on the Exhibit Index attached hereto and filed herewith.

Field: Page; Sequence: 2; Options: NewSection; Value: 2

2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the city of Somerset, State of New Jersey on October 10, 2018.

| Medical Transcription
Billing, Corp. | |
| --- | --- |
| By: | /s/
Stephen Snyder |
| | Stephen
Snyder |
| | Chief
Executive Officer |

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature	Title
/s/
Mahmud Haq	October
10, 2018
Mahmud
Haq	Executive
Chairman and Director
/s/
Stephen Snyder	October
10, 2018
Stephen
Snyder	Principal
Executive Officer and Director
/s/
Bill Korn	October
10, 2018
Bill
Korn	Principal
Financial Officer
/s/
Norman Roth	October
10, 2018
Norman
Roth	Principal
Accounting Officer
*	October
10, 2018
A.
Hadi Chaudhry	President
*	October
10, 2018
Anne
Busquet	Director
*	October
10, 2018
Howard
L. Clark, Jr.	Director
*	October
10, 2018
John
N. Daly	Director
*	October
10, 2018
Cameron
Munter	Director

| *
By: |
| --- |
| Stephen
Snyder Attorney-in-fact |

Field: Page; Sequence: 3; Value: 2

3

Field: /Page

EXHIBIT INDEX

| Exhibit Number | Exhibit
Description |
| --- | --- |
| 5.1
* | Opinion
of Song P.C. |
| 23.1
* | Consent
of Grant Thornton LLP. |
| 23.2
* | Consent of Montgomery Coscia Greilich LLP. |
| 23.3
* | Consent
of Song P.C. (included in Exhibit 5.1). |
| 24.1 | Power
of Attorney for Directors of the Company (filed as Exhibit 24.1 to the Company’s Form S-1 filed on September 25, 2018,
and incorporated herein by reference). |
| | * Filed herewith. |

Field: Page; Sequence: 4; Value: 2

4

Field: /Page